Cargando…

Parenteral vs. oral sumatriptan and naratriptan: plasma levels and efficacy in migraine. A comment

The clinical efficacy in migraine was compared for oral and subcutaneous sumatriptan and naratriptan. Doses of the two administration forms were chosen as resulting in comparable blood concentrations. Subcutaneous administrations of the drugs were superior for efficacy than the oral forms. This most...

Descripción completa

Detalles Bibliográficos
Autor principal: Tfelt-Hansen, Peer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3476154/
https://www.ncbi.nlm.nih.gov/pubmed/17955173
http://dx.doi.org/10.1007/s10194-007-0411-x
_version_ 1782247060693581824
author Tfelt-Hansen, Peer
author_facet Tfelt-Hansen, Peer
author_sort Tfelt-Hansen, Peer
collection PubMed
description The clinical efficacy in migraine was compared for oral and subcutaneous sumatriptan and naratriptan. Doses of the two administration forms were chosen as resulting in comparable blood concentrations. Subcutaneous administrations of the drugs were superior for efficacy than the oral forms. This most likely due to a quicker rise in blood concentrations after subcutaneous injections.. In designing new therapies for migraine one should aim at a quick absorption of the drug, which will probably result in an increased efficacy.
format Online
Article
Text
id pubmed-3476154
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher Springer-Verlag
record_format MEDLINE/PubMed
spelling pubmed-34761542012-11-29 Parenteral vs. oral sumatriptan and naratriptan: plasma levels and efficacy in migraine. A comment Tfelt-Hansen, Peer J Headache Pain Comment The clinical efficacy in migraine was compared for oral and subcutaneous sumatriptan and naratriptan. Doses of the two administration forms were chosen as resulting in comparable blood concentrations. Subcutaneous administrations of the drugs were superior for efficacy than the oral forms. This most likely due to a quicker rise in blood concentrations after subcutaneous injections.. In designing new therapies for migraine one should aim at a quick absorption of the drug, which will probably result in an increased efficacy. Springer-Verlag 2007-10-23 2007-10 /pmc/articles/PMC3476154/ /pubmed/17955173 http://dx.doi.org/10.1007/s10194-007-0411-x Text en © Springer-Verlag Italia 2007
spellingShingle Comment
Tfelt-Hansen, Peer
Parenteral vs. oral sumatriptan and naratriptan: plasma levels and efficacy in migraine. A comment
title Parenteral vs. oral sumatriptan and naratriptan: plasma levels and efficacy in migraine. A comment
title_full Parenteral vs. oral sumatriptan and naratriptan: plasma levels and efficacy in migraine. A comment
title_fullStr Parenteral vs. oral sumatriptan and naratriptan: plasma levels and efficacy in migraine. A comment
title_full_unstemmed Parenteral vs. oral sumatriptan and naratriptan: plasma levels and efficacy in migraine. A comment
title_short Parenteral vs. oral sumatriptan and naratriptan: plasma levels and efficacy in migraine. A comment
title_sort parenteral vs. oral sumatriptan and naratriptan: plasma levels and efficacy in migraine. a comment
topic Comment
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3476154/
https://www.ncbi.nlm.nih.gov/pubmed/17955173
http://dx.doi.org/10.1007/s10194-007-0411-x
work_keys_str_mv AT tfelthansenpeer parenteralvsoralsumatriptanandnaratriptanplasmalevelsandefficacyinmigraineacomment